The Global Therapeutic Plasma Exchange Market to grow from USD 390.86 Million in 2019 to USD 634.22 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 8.40%.
Market Segmentation & Coverage:
The research report categorizes the Therapeutic Plasma Exchange Market to forecast the revenues and analyze the trends in each of the following segments:
Based on Technology, the Therapeutic Plasma Exchange Market studied across Centrifugation and Membrane Separation.
Based on Indication, the Therapeutic Plasma Exchange Market studied across Hematologic Disorders, Metabolic Disorders, Neurological Disorders, and Renal Disorders. The Hematologic Disorders further studied across Atypical Hemolytic Uremic Syndrome, Hyperviscosity Syndrome, Severe/Symptomatic Cryoglobulinemia, and Thrombotic Thrombocytopenic Purpura. The Neurological Disorders further studied across Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barré Syndrome, Multiple Sclerosis, Myasthenia Gravis, and PANDAS. The Renal Disorders further studied across Antibody-mediated Renal Transplant Rejection, Goodpasture Syndrome, and Wegener's Granulomatosis.
Based on Product , the Therapeutic Plasma Exchange Market studied across Consumables and Devices.
Based on End-user, the Therapeutic Plasma Exchange Market studied across Blood Collection Centers & Blood Component Providers and Hospitals & Transfusion Centers.
"The Asia-Pacific is projected to witness the highest growth during the forecast period"
Based on Geography, the Therapeutic Plasma Exchange Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Therapeutic Plasma Exchange Market in 2019, followed by the Europe, Middle East & Africa. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.
The factors attributing to the growth of the market are rise in applications of therapeutic plasma exchange, increase in the prevalence of chronic diseases, and innumerable usages of the therapeutic plasma exchange in the treatment. However, some factors such as cost associated with the devices and therapeutic plasma exchange procedures may hinder the market growth. The Therapeutic Plasma Exchange Market expected to showcase the opportunities such as increasing number of government licensed and accredited blood banks and increased government focus on healthcare infrastructure development coupled with easy access to affordable healthcare. Soon market may face the possible challenges in the growth due to limited availability of skilled professionals. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Therapeutic Plasma Exchange Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Company Usability Profiles:
The Therapeutic Plasma Exchange Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Therapeutic Plasma Exchange Market, including Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, Fresenius SE & Co. KGaA, Grifols, SA, Haemonetics Corporation, HemaCare, Infomed SA, Kaneka Corporation, Kawasumi Laboratories, Inc., Medica S.p.A., Medicap Clinic GmbH, MEISE Medizintechnik GmbH, Miltenyi Biotec, Nikkiso Co., Ltd., NxStage Medical, Inc., Takeda Pharmaceutical Company Limited, and Terumo BCT, Inc..